Thermo Fisher Scientific
TMO
1,674 hedge funds and large institutions have $99.8B invested in Thermo Fisher Scientific in 2020 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 614 increasing their positions, 734 reducing their positions, and 111 closing their positions.
19% more first-time investments, than exits
New positions opened: 132 | Existing positions closed: 111
13% more funds holding in top 10
Funds holding in top 10: 141 → 159 (+18)
0% less funds holding
Funds holding: 1,678 → 1,674 (-4)
0.74% less ownership
Funds ownership: 89.09% → 88.35% (-0.74%)
14% less capital invested
Capital invested by funds: $116B → $99.8B (-$16.1B)
16% less repeat investments, than reductions
Existing positions increased: 614 | Existing positions reduced: 734
17% less call options, than puts
Call options by funds: $330M | Put options by funds: $397M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$392M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$297M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$296M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$164M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$152M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$395M |
| 2 |
BlackRock
New York
|
-$371M |
| 3 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
-$304M |
| 4 |
MG
Meritage Group
San Francisco,
California
|
-$267M |
| 5 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$260M |
TMO Hedge Fund Activity: Q1 2020 in Review
1,674 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2020, worth a combined $99.8B — down 14% from $116B a quarter earlier.
Buyers outnumbered sellers: 132 funds opened new TMO positions and 111 closed out — a net gain of 21 holders — while 614 added to existing stakes and 734 trimmed.
The largest buyer was Capital World Investors, adding an estimated $392M. The largest seller was Fidelity Investments, cutting an estimated $395M.
- 1,674 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2020, down from 1,678 in Q4 2019.
- Funds reported $99.8B of Thermo Fisher Scientific stock for Q1 2020, down 14% quarter-over-quarter.
- 132 funds opened new Thermo Fisher Scientific positions in Q1 2020 and 111 closed out, a net change of +21 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2020 was Capital World Investors, an estimated $392M added.
- The largest Thermo Fisher Scientific seller in Q1 2020 was Fidelity Investments, an estimated $395M sold.
Based on aggregated 13F filings for Q1 2020.